Exploring the role of external experts in supporting staff to implement psychosocial interventions in care home settings: results from the process evaluation of a randomized controlled trial.

Care homes Dementia care mapping External expert Intervention implementation Long-term care Practice development Process evaluation Psychosocial interventions Qualitative

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
04 Nov 2019
Historique:
received: 26 06 2019
accepted: 21 10 2019
entrez: 6 11 2019
pubmed: 7 11 2019
medline: 23 1 2020
Statut: epublish

Résumé

Psychosocial interventions offer opportunities to improve care for people with dementia in care homes. However, implementation is often led by staff who are not well prepared for the role. Some interventions use external experts to support staff. However little is known about external expert, care home staff and manager perceptions of such support. This paper addresses this gap. Multi-methods study within a process evaluation of a cluster randomised controlled trial of Dementia Care Mapping™ (DCM). Interviews were conducted with six external experts who also completed questionnaires, 17 care home managers and 25 care home staff responsible for DCM implementation. Data were analysed using descriptive statistics and template analysis. Three themes were identified: the need for expert support, practicalities of support and broader impacts of providing support. Expert support was vital for successful DCM implementation, although the five-days provided was felt to be insufficient. Some homes felt the support was inflexible and did not consider their individual needs. Practical challenges of experts being located at a geographical distance from the care homes, limited when and how support was available. Experts gained knowledge they were able to then apply in delivering DCM training. Experts were not able to accurately predict which homes would be able to implement DCM independently in future cycles. An external expert may form a key component of successful implementation of psychosocial interventions in care home settings. Future research should explore optimal use of the expert role.

Sections du résumé

BACKGROUND BACKGROUND
Psychosocial interventions offer opportunities to improve care for people with dementia in care homes. However, implementation is often led by staff who are not well prepared for the role. Some interventions use external experts to support staff. However little is known about external expert, care home staff and manager perceptions of such support. This paper addresses this gap.
METHODS METHODS
Multi-methods study within a process evaluation of a cluster randomised controlled trial of Dementia Care Mapping™ (DCM). Interviews were conducted with six external experts who also completed questionnaires, 17 care home managers and 25 care home staff responsible for DCM implementation. Data were analysed using descriptive statistics and template analysis.
RESULTS RESULTS
Three themes were identified: the need for expert support, practicalities of support and broader impacts of providing support. Expert support was vital for successful DCM implementation, although the five-days provided was felt to be insufficient. Some homes felt the support was inflexible and did not consider their individual needs. Practical challenges of experts being located at a geographical distance from the care homes, limited when and how support was available. Experts gained knowledge they were able to then apply in delivering DCM training. Experts were not able to accurately predict which homes would be able to implement DCM independently in future cycles.
CONCLUSIONS CONCLUSIONS
An external expert may form a key component of successful implementation of psychosocial interventions in care home settings. Future research should explore optimal use of the expert role.

Identifiants

pubmed: 31684943
doi: 10.1186/s12913-019-4662-4
pii: 10.1186/s12913-019-4662-4
pmc: PMC6829988
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

790

Subventions

Organisme : Department of Health
ID : 11/15/13
Pays : United Kingdom
Organisme : Health Technology Assessment Programme
ID : 11/15/13

Références

Lancet Neurol. 2009 Apr;8(4):317-25
pubmed: 19282246
Dementia (London). 2020 Feb;19(2):237-252
pubmed: 29699408
Am J Alzheimers Dis Other Demen. 2019 Sep;34(6):390-398
pubmed: 31056923
Qual Res Psychol. 2015 Apr 3;12(2):202-222
pubmed: 27499705
Dementia (London). 2016 Sep;15(5):1158-70
pubmed: 25370077
Dement Geriatr Cogn Disord. 2013;36(5-6):340-53
pubmed: 24022375
Dementia (London). 2019 Oct-Nov;18(7-8):3059-3070
pubmed: 29631493
Int Psychogeriatr. 2015 Nov;27(11):1875-92
pubmed: 26138674
J Clin Nurs. 2017 Mar;26(5-6):751-765
pubmed: 27534732
Int Psychogeriatr. 2015 Jan;27(1):19-35
pubmed: 25093383
BMC Geriatr. 2019 Feb 8;19(1):37
pubmed: 30736748
PLoS One. 2013 Jul 02;8(7):e67325
pubmed: 23844003
Aging Ment Health. 2020 Jan;24(1):178-185
pubmed: 30569749
Clin Interv Aging. 2018 Jan 26;13:165-177
pubmed: 29416325
Br J Psychiatry. 2012 Nov;201(5):344-51
pubmed: 23118034
BMC Med Res Methodol. 2014 Apr 05;14:47
pubmed: 24708761
Int Psychogeriatr. 2017 Oct;29(10):1713-1722
pubmed: 28651659
Worldviews Evid Based Nurs. 2018 Oct;15(5):361-367
pubmed: 30022601
PLoS Med. 2018 Feb 6;15(2):e1002500
pubmed: 29408901
Aging Ment Health. 2007 May;11(3):237-45
pubmed: 17558574
Health Technol Assess. 2020 Mar;24(16):1-172
pubmed: 32216870
Int J Geriatr Psychiatry. 2014 Aug;29(8):797-807
pubmed: 24535885
BMJ. 2006 Apr 1;332(7544):756-61
pubmed: 16543297
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Trials. 2016 Jun 24;17(1):300
pubmed: 27341812
BMJ Open. 2017 Feb 9;7(2):e014177
pubmed: 28183810
Int Psychogeriatr. 2017 Oct;29(10):1609-1618
pubmed: 28629482
Int J Older People Nurs. 2018 Jun;13(2):e12184
pubmed: 29363270
Int J Geriatr Psychiatry. 2016 Mar;31(3):284-93
pubmed: 26192078
Int J Nurs Stud. 2018 Jun;82:1-10
pubmed: 29573591

Auteurs

Claire A Surr (CA)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK. c.a.surr@leedsbeckett.ac.uk.

Emily Shoesmith (E)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK.

Alys W Griffiths (AW)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK.

Rachael Kelley (R)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, LS1 3HE, UK.

Joanne McDermid (J)

Kings College London, London, UK.

Jane Fossey (J)

Oxford Health NHS Foundation Trust, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH